Press Releases :: Beyond Air Inc. (XAIR)

Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors

Nov 04, 2021 7:30am EDT

Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Nov 02, 2021 8:00am EDT

Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast

Oct 25, 2021 8:00am EDT

Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease

Oct 20, 2021 8:00am EDT

Beyond Air® Provides Global Regulatory Update for LungFit® PH

Sep 21, 2021 4:30pm EDT

Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 14, 2021 7:30am EDT

Beyond Air® Announces CFO Transition

Aug 20, 2021 4:15pm EDT

Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022

Aug 10, 2021 4:05pm EDT

Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast

Jul 20, 2021 7:30am EDT

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021

Jul 08, 2021 4:14pm EDT

1
2
3
4
5
6
7
8
9
10
...17

Important Safety Information

^†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.